6 variations in causes of death in children undergoing surgery for congenital cardiac malformations,” Cardiology in the Young, vol. 17, no. 4, pp. 423–431, 2007. [5] C. M. Lo´ pez, L. Garc´ıa-Guereta, and CIVIC Study Group, “Community-acquired respiratory infections in young chil- dren with congenital heart diseases in the palivizumab era,” Pediatric Infectious Disease Journal, vol. 29, no. 12, pp. 1077– 1082, 2010. [6] K. N. Carroll, T. Gebretsadik, M. R. Griﬃn et al., “Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan,” Pediatrics, vol. 122, no. 1, pp. 58–64, 2008. [7] C. G. Garcia, R. Bhore, A. Soriano-Fallas et al., “Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis,” Pediatrics, vol. 126, no. 6, pp. e1453–e1460, 2010. [8] C. B. Hall, “Respiratory syncytial virus and parainﬂuenza virus,” The New England Journal of Medicine, vol. 344, no. 25, pp. 1917–1928, 2001. [9] T. F. Feltes, A. K. Cabalka, H. C. Meissner et al., “Palivizumab prophylaxis reduces hospitalization due to respiratory syncy- tial virus in young children with hemodynamically signiﬁcant congenital heart disease,” Journal of Pediatrics, vol. 143, no. 4, pp. 532–540, 2003. [10] A. Meberg and A.-L. Bruu, “Respiratory syncytial virus infections in congenital heart defects—hospitalizations and costs,” Acta Paediatrica, vol. 95, no. 4, pp. 404–406, 2006. [11] K. Thorburn, “Pre-existing disease is associated with a signiﬁ- cantly higher risk of death in severe respiratory syncytial virus infection,” Archives of Disease in Childhood, vol. 94, no. 2, pp. 99–103, 2009. [12] H. Nair, D. J. Nokes, B. D. Gessner et al., “Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta- analysis,” The Lancet, vol. 375, no. 9725, pp. 1545–1555, 2010. [13] S. Ralston and R. Hill, “Incidence of apnea in infants hospitalized with respiratory syncytial virus bronchiolitis: a systematic review,” Journal of Pediatrics, vol. 155, no. 5, pp. 728–733, 2009. [14] A. K. Cabalka, “Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease,” Pedi- atric Infectious Disease Journal, vol. 23, no. 1, supplement, pp. S41–S45, 2004. [15] N. E. MacDonald, C. B. Hall, and S. C. Suﬃn, “Respiratory syncytial viral infection in infants with congenital heart disease,” The New England Journal of Medicine, vol. 307, no. 7, pp. 397–400, 1982. [16] F. W. Moler, A. S. Khan, J. N. Meliones, J. R. Custer, J. Palmisano, and T. C. Shope, “Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience,” Critical Care Medicine, vol. 20, no. 10, pp. 1406–1413, 1992. [17] A. Khongphatthanayothin, P. Wong, Y. Samara et al., “Impact of respiratory syncytial virus infection on surgery for congen- ital heart disease: postoperative course and outcome,” Critical Care Medicine, vol. 27, no. 9, pp. 1974–1981, 1999. [18] C. A. Altman, J. A. Englund, G. Demmler et al., “Respiratory syncytial virus in patients with congenital heart disease: a con- temporary look at epidemiology and success of preoperative screening,” Pediatric Cardiology, vol. 21, no. 5, pp. 433–438, 2000. [19] K. Kristensen, L. G. Stensballe, J. Bjerre et al., “Risk factors for respiratory syncytial virus hospitalisation in children with International Journal of Pediatrics heart disease,” Archives of Disease in Childhood, vol. 94, no. 10, pp. 785–789, 2009. [20] M. Fabbiani, C. Terrosi, B. Martorelli et al., “Epidemiological and clinical study of viral respiratory tract infections in children from Italy,” Journal of Medical Virology, vol. 81, no. 4, pp. 750–756, 2009. [21] D. Miron, I. Srugo, Z. Kra-Oz et al., “Sole pathogen in acute bronchiolitis: is there a role for other organisms apart from respiratory syncytial virus?” Pediatric Infectious Disease Journal, vol. 29, no. 1, pp. e7–e10, 2010. [22] C. Calvo, F. Pozo, M. L. Garc´ıa-Garc´ıa et al., “Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study,” Acta Paediatrica, vol. 99, no. 6, pp. 883–887, 2010. [23] N. G. Papadopoulos, M. Moustaki, M. Tsolia et al., “Associ- ation of rhinovirus infection with increased disease severity in acute bronchiolitis,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 9, pp. 1285–1289, 2002. [24] M. G. Semple, A. Cowell, W. Dove et al., “Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis,” Journal of Infectious Diseases, vol. 191, no. 3, pp. 382–386, 2005. [25] F. Midulla, C. Scagnolari, E. Bonci et al., “Respiratory syncy- tial virus, human bocavirus and rhinovirus bronchiolitis in infants,” Archives of Disease in Childhood, vol. 95, no. 1, pp. 35–41, 2010. [26] N. Richard, F. Komurian-Pradel, E. Javouhey et al., “The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis,” Pediatric Infectious Disease Journal, vol. 27, no. 3, pp. 213–217, 2008. [27] J. O. Wishaupt, A. Russcher, L. C. Smeets, F. G. A. Versteegh, and N. G. Hartwig, “Clinical impact of RT-PCR for pediatric acute respiratory infections: a controlled clinical trial,” Pedi- atrics, vol. 128, no. 5, pp. e1113–e1120, 2011. [28] C. B. Hall, G. A. Weinberg, M. K. Iwane et al., “The Burden of respiratory syncytial virus infection in young children,” The New England Journal of Medicine, vol. 360, no. 6, pp. 588–598, 2009. [29] D. F. Willson, L. Landrigan, S. D. Horn, and R. J. Smout, “Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia,” Journal of Pediatrics, vol. 143, no. 5, supplement, pp. S142–S149, 2003. [30] S. Esposito, P. Salice, S. Bosis et al., “Altered cardiac rhytm in infants with bronchiolitis and respiratory syncytial virus infection,” BMC Infectious Diseases, vol. 10, article 305, 2010. [31] K. Thorburn, M. Eisenhut, A. Shauq, S. Narayanswamy, and M. Burgess, “Right ventricular function in children with severe respiratory syncytial virus (RSV) bronchiolitis,” Minerva Anestesiologica, vol. 77, no. 1, pp. 46–53, 2011. [32] L. Bialy, M. Foisy, M. Smith, and R. M. Fernandes, “The cochrane library and the treatment of bronchiolitis in chil- dren: an overview of reviews,” Evidence-Based Child Health, vol. 6, pp. 258–275, 2011. [33] D. Levin, M. Tribuzio, T. Green-Wrzesinki et al., “Empiric antibiotics are justiﬁed for infants with respiratory syncytial virus lower respiratory tract infection presenting with respira- tory failure: a prospective study and evidence review,” Pediatric Critical Care Medicine, vol. 11, no. 3, pp. 390–395, 2010. [34] C. McKiernan, L. C. Chua, P. F. Visintainer, and H. Allen, “High ﬂow nasal cannulae therapy in infants with bronchioli- tis,” Journal of Pediatrics, vol. 156, no. 4, pp. 634–638, 2010.